National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer

Understanding Cancer Series: The Immune System
< Back to Main
    Posted: 01/28/2005    Reviewed: 09/01/2006
Slide 36  :  Hybridoma Technology

A hybridoma is a hybrid cell produced by injecting a specific antigen into a mouse, collecting an antibody-producing cell from the mouse's spleen, and fusing it with a long-lived cancerous immune cell called a myeloma cell. Individual hybridoma cells are cloned and tested to find those that produce the desired antibody. Their many identical daughter clones will secrete, over a long period of time, millions of identical copies of made-to-order "monoclonal" antibodies.

Thanks to hybridoma technology, scientists are now able to make large quantities of specific antibodies.

The Immune System - Hybridoma Technology